The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Animal-derived Immune Globulin Products Market Research Report 2024
Synopsis
Immune globulin (Ig) short-term protection against hepatitis A and measles
The global Animal-derived Immune Globulin Products market was valued at US$ 1241 million in 2023 and is anticipated to reach US$ 1726.3 million by 2030, witnessing a CAGR of 4.8% during the forecast period 2024-2030.
North American market for Animal-derived Immune Globulin Products is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Animal-derived Immune Globulin Products is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Animal-derived Immune Globulin Products include Pfizer, Rare Disease Therapeutics, Bioclon Institute, Merck & Co, Sanofi and BTG Specialty Pharmaceuticals, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Animal-derived Immune Globulin Products, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Animal-derived Immune Globulin Products.
Report Scope
The Animal-derived Immune Globulin Products market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Animal-derived Immune Globulin Products market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Animal-derived Immune Globulin Products manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Pfizer
Rare Disease Therapeutics
Bioclon Institute
Merck & Co
Sanofi
BTG Specialty Pharmaceuticals
Segment by Type
IVIg Liquid
IVIg Powder
Segment by Application
Immunodeficiency
Autoimmune Disease
Acute Infection
Consumption by Region
North America
the United States
Canada
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Animal-derived Immune Globulin Products manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Animal-derived Immune Globulin Products in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Immune globulin (Ig) short-term protection against hepatitis A and measles
The global Animal-derived Immune Globulin Products market was valued at US$ 1241 million in 2023 and is anticipated to reach US$ 1726.3 million by 2030, witnessing a CAGR of 4.8% during the forecast period 2024-2030.
North American market for Animal-derived Immune Globulin Products is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Animal-derived Immune Globulin Products is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Animal-derived Immune Globulin Products include Pfizer, Rare Disease Therapeutics, Bioclon Institute, Merck & Co, Sanofi and BTG Specialty Pharmaceuticals, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Animal-derived Immune Globulin Products, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Animal-derived Immune Globulin Products.
Report Scope
The Animal-derived Immune Globulin Products market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Animal-derived Immune Globulin Products market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Animal-derived Immune Globulin Products manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Pfizer
Rare Disease Therapeutics
Bioclon Institute
Merck & Co
Sanofi
BTG Specialty Pharmaceuticals
Segment by Type
IVIg Liquid
IVIg Powder
Segment by Application
Immunodeficiency
Autoimmune Disease
Acute Infection
Consumption by Region
North America
the United States
Canada
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Animal-derived Immune Globulin Products manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Animal-derived Immune Globulin Products in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Animal-derived Immune Globulin Products Market Overview
1.1 Product Overview and Scope of Animal-derived Immune Globulin Products
1.2 Animal-derived Immune Globulin Products Segment by Type
1.2.1 Global Animal-derived Immune Globulin Products Market Value Comparison by Type (2024-2030)
1.2.2 IVIg Liquid
1.2.3 IVIg Powder
1.3 Animal-derived Immune Globulin Products Segment by Application
1.3.1 Global Animal-derived Immune Globulin Products Market Value by Application: (2024-2030)
1.3.2 Immunodeficiency
1.3.3 Autoimmune Disease
1.3.4 Acute Infection
1.4 Global Animal-derived Immune Globulin Products Market Size Estimates and Forecasts
1.4.1 Global Animal-derived Immune Globulin Products Revenue 2019-2030
1.4.2 Global Animal-derived Immune Globulin Products Sales 2019-2030
1.4.3 Global Animal-derived Immune Globulin Products Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Animal-derived Immune Globulin Products Market Competition by Manufacturers
2.1 Global Animal-derived Immune Globulin Products Sales Market Share by Manufacturers (2019-2024)
2.2 Global Animal-derived Immune Globulin Products Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Animal-derived Immune Globulin Products Average Price by Manufacturers (2019-2024)
2.4 Global Animal-derived Immune Globulin Products Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Animal-derived Immune Globulin Products, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Animal-derived Immune Globulin Products, Product Type & Application
2.7 Animal-derived Immune Globulin Products Market Competitive Situation and Trends
2.7.1 Animal-derived Immune Globulin Products Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Animal-derived Immune Globulin Products Players Market Share by Revenue
2.7.3 Global Animal-derived Immune Globulin Products Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Animal-derived Immune Globulin Products Retrospective Market Scenario by Region
3.1 Global Animal-derived Immune Globulin Products Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Animal-derived Immune Globulin Products Global Animal-derived Immune Globulin Products Sales by Region: 2019-2030
3.2.1 Global Animal-derived Immune Globulin Products Sales by Region: 2019-2024
3.2.2 Global Animal-derived Immune Globulin Products Sales by Region: 2025-2030
3.3 Global Animal-derived Immune Globulin Products Global Animal-derived Immune Globulin Products Revenue by Region: 2019-2030
3.3.1 Global Animal-derived Immune Globulin Products Revenue by Region: 2019-2024
3.3.2 Global Animal-derived Immune Globulin Products Revenue by Region: 2025-2030
3.4 North America Animal-derived Immune Globulin Products Market Facts & Figures by Country
3.4.1 North America Animal-derived Immune Globulin Products Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Animal-derived Immune Globulin Products Sales by Country (2019-2030)
3.4.3 North America Animal-derived Immune Globulin Products Revenue by Country (2019-2030)
3.4.4 the United States
3.4.5 Canada
3.5 Europe Animal-derived Immune Globulin Products Market Facts & Figures by Country
3.5.1 Europe Animal-derived Immune Globulin Products Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Animal-derived Immune Globulin Products Sales by Country (2019-2030)
3.5.3 Europe Animal-derived Immune Globulin Products Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 UK
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Animal-derived Immune Globulin Products Market Facts & Figures by Country
3.6.1 Asia Pacific Animal-derived Immune Globulin Products Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Animal-derived Immune Globulin Products Sales by Country (2019-2030)
3.6.3 Asia Pacific Animal-derived Immune Globulin Products Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Animal-derived Immune Globulin Products Market Facts & Figures by Country
3.7.1 Latin America Animal-derived Immune Globulin Products Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Animal-derived Immune Globulin Products Sales by Country (2019-2030)
3.7.3 Latin America Animal-derived Immune Globulin Products Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Animal-derived Immune Globulin Products Market Facts & Figures by Country
3.8.1 Middle East and Africa Animal-derived Immune Globulin Products Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Animal-derived Immune Globulin Products Sales by Country (2019-2030)
3.8.3 Middle East and Africa Animal-derived Immune Globulin Products Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Animal-derived Immune Globulin Products Sales by Type (2019-2030)
4.1.1 Global Animal-derived Immune Globulin Products Sales by Type (2019-2024)
4.1.2 Global Animal-derived Immune Globulin Products Sales by Type (2025-2030)
4.1.3 Global Animal-derived Immune Globulin Products Sales Market Share by Type (2019-2030)
4.2 Global Animal-derived Immune Globulin Products Revenue by Type (2019-2030)
4.2.1 Global Animal-derived Immune Globulin Products Revenue by Type (2019-2024)
4.2.2 Global Animal-derived Immune Globulin Products Revenue by Type (2025-2030)
4.2.3 Global Animal-derived Immune Globulin Products Revenue Market Share by Type (2019-2030)
4.3 Global Animal-derived Immune Globulin Products Price by Type (2019-2030)
5 Segment by Application
5.1 Global Animal-derived Immune Globulin Products Sales by Application (2019-2030)
5.1.1 Global Animal-derived Immune Globulin Products Sales by Application (2019-2024)
5.1.2 Global Animal-derived Immune Globulin Products Sales by Application (2025-2030)
5.1.3 Global Animal-derived Immune Globulin Products Sales Market Share by Application (2019-2030)
5.2 Global Animal-derived Immune Globulin Products Revenue by Application (2019-2030)
5.2.1 Global Animal-derived Immune Globulin Products Revenue by Application (2019-2024)
5.2.2 Global Animal-derived Immune Globulin Products Revenue by Application (2025-2030)
5.2.3 Global Animal-derived Immune Globulin Products Revenue Market Share by Application (2019-2030)
5.3 Global Animal-derived Immune Globulin Products Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Pfizer
6.1.1 Pfizer Corporation Information
6.1.2 Pfizer Description and Business Overview
6.1.3 Pfizer Animal-derived Immune Globulin Products Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Pfizer Animal-derived Immune Globulin Products Product Portfolio
6.1.5 Pfizer Recent Developments/Updates
6.2 Rare Disease Therapeutics
6.2.1 Rare Disease Therapeutics Corporation Information
6.2.2 Rare Disease Therapeutics Description and Business Overview
6.2.3 Rare Disease Therapeutics Animal-derived Immune Globulin Products Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Rare Disease Therapeutics Animal-derived Immune Globulin Products Product Portfolio
6.2.5 Rare Disease Therapeutics Recent Developments/Updates
6.3 Bioclon Institute
6.3.1 Bioclon Institute Corporation Information
6.3.2 Bioclon Institute Description and Business Overview
6.3.3 Bioclon Institute Animal-derived Immune Globulin Products Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Bioclon Institute Animal-derived Immune Globulin Products Product Portfolio
6.3.5 Bioclon Institute Recent Developments/Updates
6.4 Merck & Co
6.4.1 Merck & Co Corporation Information
6.4.2 Merck & Co Description and Business Overview
6.4.3 Merck & Co Animal-derived Immune Globulin Products Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Merck & Co Animal-derived Immune Globulin Products Product Portfolio
6.4.5 Merck & Co Recent Developments/Updates
6.5 Sanofi
6.5.1 Sanofi Corporation Information
6.5.2 Sanofi Description and Business Overview
6.5.3 Sanofi Animal-derived Immune Globulin Products Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Sanofi Animal-derived Immune Globulin Products Product Portfolio
6.5.5 Sanofi Recent Developments/Updates
6.6 BTG Specialty Pharmaceuticals
6.6.1 BTG Specialty Pharmaceuticals Corporation Information
6.6.2 BTG Specialty Pharmaceuticals Description and Business Overview
6.6.3 BTG Specialty Pharmaceuticals Animal-derived Immune Globulin Products Sales, Revenue and Gross Margin (2019-2024)
6.6.4 BTG Specialty Pharmaceuticals Animal-derived Immune Globulin Products Product Portfolio
6.6.5 BTG Specialty Pharmaceuticals Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Animal-derived Immune Globulin Products Industry Chain Analysis
7.2 Animal-derived Immune Globulin Products Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Animal-derived Immune Globulin Products Production Mode & Process
7.4 Animal-derived Immune Globulin Products Sales and Marketing
7.4.1 Animal-derived Immune Globulin Products Sales Channels
7.4.2 Animal-derived Immune Globulin Products Distributors
7.5 Animal-derived Immune Globulin Products Customers
8 Animal-derived Immune Globulin Products Market Dynamics
8.1 Animal-derived Immune Globulin Products Industry Trends
8.2 Animal-derived Immune Globulin Products Market Drivers
8.3 Animal-derived Immune Globulin Products Market Challenges
8.4 Animal-derived Immune Globulin Products Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
